SKLB-C05

CAT: 0804-HY-122860Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-122860Size:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
SKLB-C05 is a novel selective, orally active TOPK inhibitor, with an IC50 of 0.5 nM. SKLB-C05 selectively inhibit TOPK kinase. SKLB-C05 induces Apoptosis, downregulates c-Myc, γ-H2AX, activates p53, blocks FAK/Src medicated migration-related signaling. SKLB-C05 disturbs cell mitosis. SKLB-C05 shows anticancer activity only against TOPK-positive colorectal cancer[1].
CAS Number
[2300981-68-2]
UNSPSC
12352005
Target
Apoptosis; c-Myc; FAK; MDM-2/p53; Mitosis; Src; TOPK
Related Pathways
Apoptosis; Cell Cycle/DNA Damage; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Smiles
O=C1NC2=C(C)C=C(O)C(C3=CC=C(C=C3)[C@H](CN)C)=C2C4=C1C=CC=C4.Cl
Molecular Formula
C23H23ClN2O2
Molecular Weight
394.89
References & Citations
[1]Gao T, et al. Novel selective TOPK inhibitor SKLB-C05 inhibits colorectal carcinoma growth and metastasis. Cancer Lett. 2019 Mar 31;445:11-23.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-18947-01SKLB-23bb
HY-144217-01SKLB-197
HY-120429-01SKLB-163
HY-178114SKLB-0124
HY-177497SKLB-03220
HY-176848-01SKLB-Y13
HY-173572-01SKLB-11A
HY-178102SKLB-0266
HY-173119-01SKLB-D18

Alternative Products

CatalogName
M10442-01SKLB 610
M27829-01SKLB-163
MBS3842805-01SKLB-23bb
T34656-01SKLB 1028
TRC-S555010-250MGSKLB-1028
T210843-01SKLB-11A
T207811-01SKLB-03220
T62290-01SKLB-197
T206864-01SKLB-D18

Popular Products